Literatur

• Literatur

• 1 Bedell SE, Delbanco TL, Cook EF. et al. Survival after cardiopulmonary resuscitation in the hospital. N Engl J Med 1983; 309: 569-576.
• 2 Böttiger BW, Grabner C, Bauer H. et al. Long term outcome after out-of-hospital cardiac arrest with physician staffed emergency medical services: the Utstein style applied to a midsized urban/suburban area. Heart 1999; 82: 674-679.
• 3 Newman DH, Greenwald I, Callaway CW. Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med 2000; 35: 472-480.
• 4 Bunch TJ, White RD, Gersh BJ. et al. Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med 2003; 348: 2626-2633.
• 5 Hypothermia after Cardiac Arrest Study Group.. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346: 549-556.
• 6 Brain Resuscitation Clinical Trial I Study Group.. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 1986; 314: 397-403.
• 7 Brain Resuscitation Clinical Trial II Study Group.. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. Brain Resuscitation Clinical Trial II Study Group. N Engl J Med 1991; 324: 1225-1231.
• 8 Kudenchuk PJ, Cobb LA, Copass MK. et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999; 341: 871-878.
• 9 Silfvast T. Cause of death in unsuccessful prehospital resuscitation. J Intern Med 1991; 229: 331-335.
• 10 Spaulding CM, Joly LM, Rosenberg A. et al. Immediate coronary angiography in survivors of outof-hospital cardiac arrest. N Engl J Med 1997; 336: 1629-1633.
• 11 Padosch SA, Motsch J, Böttiger BW. Thrombolysis during cardiopulmonary resuscitation. Anaesthesist 2002; 51: 516-532.
• 12 Crowell J, Sharpe G, Lambright R. et al. The mechanism of death after resuscitation following acute circulatory failure. Surgery 1955; 38: 696-702.
• 13 Lin SR, O’Connor MJ, Fischer HW. et al. The effect of combined dextran and streptokinase on cerebral function and blood flow after cardiac arrest: and experimental study on the dog. Invest Radiol 1978; 13: 490-498.
• 14 Fischer M, Böttiger BW, Popov-Cenic S. et al. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med 1996; 22: 1214-1223.
• 15 Böttiger BW, Motsch J, Böhrer H. et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 1995; 92: 2572-2578.
• 16 Renkes-Hegendörfer U, Herrmann K. Successful treatment of a case of fulminant massive pulmonary embolism with streptokinase. Anaesthesist 1974; 23: 500-501.
• 17 Sheth A, Cullinan P, Vachharajani V. et al. Bolus thrombolytic infusion during prolonged refractory cardiac arrest of undiagnosed cause. Emerg Med J 2006; 23: e19.
• 18 Kürkciyan I, Meron G, Sterz F. et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med 2000; 160: 1529-1535.
• 19 Ruiz-Bailén M, Aguayo de Hoyos E, Serrano-Córcoles MC. et al. Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care Med 2001; 27: 1050-1057.
• 20 Van Campen LC, van Leeuwen GR, Verheugt FW. Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation. Am J Cardiol 1994; 73: 953-955.
• 21 Janata K, Holzer M, Kurkciyan I. et al. Major bleeding complications in cardiopulmonary resuscitation: the place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism. Resuscitation 2003; 57: 49-55.
• 22 Kürkciyan I, Meron G, Sterz F. et al. Major bleeding complications after cardiopulmonary resuscitation: impact of thrombolytic treatment. J Intern Med 2003; 253: 128-135.
• 23 Lederer W, Lichtenberger C, Pechlaner C. et al. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 2001; 50: 71-76.
• 24 Schreiber W, Gabriel D, Sterz F. et al. Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. Resuscitation 2002; 52: 63-69.
• 25 Stadlbauer KH, Krismer AC, Arntz HR. et al. Effects of thrombolysis during out-of-hospital cardiopulmonary resuscitation. Am J Cardiol 2006; 97: 305-308.
• 26 Wenzel V, Krismer AC, Arntz HR. et al. A comparison of vasopressin and epinephrine for out-ofhospital cardiopulmonary resuscitation. N Engl J Med 2004; 350: 105-113.
• 27 Böttiger BW, Bode C, Kern S. et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 2001; 357: 1583-1585.
• 28 Li X, Fu QL, Jing XL. et al. A meta-analysis of cardiopulmonary resuscitation with and without the administration of thrombolytic agents. Resuscitation 2006; 70: 31-36.
• 29 Bozeman WP, Kleiner DM, Ferguson KL. Empiric tenecteplase is associated with increased return of spontaneous circulation and short term survival in cardiac arrest patients unresponsive to standard interventions. Resuscitation 2006; 69: 399-406.
• 30 Fatovich DM, Dobb GJ, Clugston RA. A pilot randomised trial of thrombolysis in cardiac arrest (The TICA trial). Resuscitation 2004; 61: 309-313.
• 31 Klefisch F, Gareis R, Störk T. et al. Präklinische ultima-ratio Thrombolyse bei therapierefraktärer kardiopulmonaler Reanimation. Intensivmedizin 1995; 32: 155-162.
• 32 Böttiger BW, Padosch SA, Wenzel V. et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002; 347: 1281-1282.
• 33 Spöhr F, Arntz HR, Bluhmki E. et al. International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: the Thrombolysis in Cardiac Arrest (TROICA) Study. Eur J Clin Invest 2005; 35: 315-323.
• 34 Nolan JP, Deakin CD, Soar J. et al. European Resuscitation Council Guidelines for Resuscitation 2005 Section 4. Adult advanced life support. Resuscitation 2005; 67 (Suppl. 01) S39-S86.
• 35 Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients.. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Lancet 1994; 343: 311-322.
• 36 Spöhr F, Böttiger BW. Safety of thrombolysis during cardiopulmonary resuscitation. Drug Saf 2003; 26: 367-379.
• 37 Krischer JP, Fine EG, Davis JH. et al. Complications of cardiac resuscitation. Chest 1987; 92: 287-291.
• 38 Powner DJ, Holcombe PA, Mello LA. Cardiopulmonary resuscitation-related injuries. Crit Care Med 1984; 12: 54-55.
• 39 Abu-Laban RB, Christenson JM, Innes GD. et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002; 346: 1522-1528.